MedMind Technology Co.
About MedMind Technology Co.
MedMind Technology Co. is a healthcare AI company that develops deep learning-based AI software for radiation oncology. Their software, such as RT-Mind-AI, focuses on automating contouring of tumor targets and organs at risk in non-contrast CT images, which is crucial for treatment planning, evaluation, and adaptation in radiation therapy. This technology aims to streamline clinical workflows and enhance precision in cancer treatment by providing automated image segmentation and analysis.
Beyond radiation oncology, MedMind Technology Limited, a company incubated by Hong Kong Science Park and City University of Hong Kong, also specializes in AI and gamification technologies for elderly care solutions, with a focus on healthy aging and addressing dementia and other mental health disorders. Their product, “NeuroGym,” is an interactive cognitive training, monitoring, and gaming platform designed to provide engaging and personalized training for the elderly, facilitate longitudinal disease monitoring, and offer early screening for conditions like dementia. This platform collects and analyzes cognitive data using machine learning models to assist caretakers and healthcare professionals in monitoring and assessing the conditions of older adults and providing timely interventions. MedMind’s broader vision is to leverage AI to make healthcare more efficient, accurate, and patient-centered, automating tasks like medical history taking and expanding into real-time assessment and planning to offer deep insights and guidance for medical treatments.
Focus Areas
Business Intelligence
| Technology | deep learning-based AI software, gamification technologies, machine learning models |
What Physicians Need to Know
For physicians, MedMind Technology's tools, particularly NeuroGym, offer a unique approach to cognitive assessment and intervention for elderly patients, leveraging gamification and culturally relevant content to enhance engagement and adherence. The AI-driven reporting provides objective data for monitoring cognitive health and informing treatment plans. Their focus on automating medical history and real-time assessment can significantly reduce administrative burden, allowing more time for direct patient care and enhancing decision-making with comprehensive data analysis. Physicians should consider how these tools can be integrated into existing workflows for early detection, personalized rehabilitation, and improved patient satisfaction, especially in settings dealing with geriatric care and cognitive decline.
MedMind's AI health assistant is built with a full RAG + LLM stack, utilizing FAISS and a fine-tuned BERT model for matching patient questions with trusted medical sources. The FastAPI backend is designed as a reusable API, suggesting potential for integration into existing clinic websites, mobile apps, or internal dashboards for triage and patient education. NeuroGym also supports various application methods, including individual training, in-person multiplayer via smart tables, online multiplayer, and Zoom for home training, indicating flexibility in deployment.
What the Web Says
MedMind Technology Co. is a health-tech company specializing in AI-powered solutions for radiotherapy planning and medical image processing. Their product, RT-Mind-AI, is FDA-cleared and aims to improve the accuracy and efficiency of contouring clinical target volumes and organs at risk in cancer treatment. The company's technology has been evaluated in several clinical studies, demonstrating promising results in various cancer types.
Overall: PositiveStrengths
- AI-powered auto-segmentation for radiotherapy planning
- FDA-cleared product (RT-Mind-AI)
- Improved consistency and efficiency in contouring
- Demonstrated accuracy in clinical studies for various cancer types (e.g., rectal, breast, lung)
- Reduces workload for medical professionals
- Potential to enhance clinical application and decision-making
Limitations
- Limited information on company culture or employer reviews from common platforms (G2, Glassdoor, Capterra, Reddit)
- Some studies note limitations such as lack of assessment on treatment effect correlation and recurrence data
- Auto-contouring accuracy may be affected by different CT slice thicknesses
- Challenges with artifacts caused by pacemakers or contrast-injected CT images
- Lower accuracy for certain organs or complex anatomical structures (e.g., bowel bag, esophagus)
Based on reviews from: FDA-cleared directory (Vertex AI Search), Innolitics (Vertex AI Search), accessdata.fda.gov, Spandidos Publications, Asia-Pacific Artificial Intelligence/ Machine Learning Medical Device (Vertex AI Search), Artificial intelligence in automatic image segmentation system for exploring recurrence patterns in small cell carcinoma of the lung - PMC, University of Groningen Generating synthetic computed tomography for radiotherapy: SynthRAD2023 challenge report Huijben, Evi, Prediction of pCR based on clinical-radiomic model in patients with locally advanced ESCC treated with neoadjuvant immunotherapy plus chemoradiotherapy - Frontiers, Full article: Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network - Taylor & Francis, Generating Synthetic Computed Tomography for Radiotherapy: SynthRAD2023 Challenge Report - arXiv, Region-specific Multi-Omics Modeling for Predicting Acute Radiation-Induced Proctitis in Cervical Cancer Radiotherapy: A Retrospective Analysis - PMC, Auto‐segmentation of the clinical target volume using a domain‐adversarial neural network in patients with gynaecological cancer undergoing postoperative vaginal brachytherapy - PMC, Clinical target volume automatic segmentation based on lymph node stations for lung cancer with bulky lump lymph nodes - PMC, Prediction of pCR based on clinical-radiomic model in patients with locally advanced ESCC treated with neoadjuvant immunotherapy plus chemoradiotherapy - PMC
Last updated: 2026-10-18
Videos
News, demos, and interviews about MedMind Technology Co..
Videos load interactively. If none appear, search YouTube for MedMind Technology Co. →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]
Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]